Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 3

The SEQUOIA Trial of Zanubrutinib vs BR in Previously Untreated CLL/SLL

,

Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss findings from the SEQUOIA trial of zanubrutinib in treatment-naive chronic lymphocytic leukemia.